{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:48:07Z","timestamp":1768528087136,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic kidney disease (DKD) is a serious microvascular complication of type 2 diabetes mellitus (T2DM). miR-127-3p is dysregulated in T2DM, but the specific molecular mechanism remains unclear. We aim to probe the diagnostic value of miR-127-3p and its molecular mechanism in T2DM and DKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study comprised 218 individuals, including 78 patients with T2DM, 72 patients with DKD and 68 healthy controls. All participants underwent fasting peripheral blood collection. In vitro, we simulated a hyperglycemic environment by treating human mesangial cells (HMC) with high-concentration glucose (HG). Subsequently, RT-qPCR was used to detect the levels of miR-127-3p in serum and HMC. Cell viability and inflammatory cytokine (TNF-\u03b1, IL-1\u03b2 and IL-6) levels were assessed using the CCK-8 assay and ELISA, respectively. The dual-luciferase reporter assay validated the target relationship between miR-127-3p and ACO2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>By comparing baseline clinical characteristics, we identified significant differences among the three groups in high density lipoprotein cholesterol (HDL-C), triglycerides (TG), fasting blood glucose (FBG), glycated hemoglobin A1c (HbA1c), blood urea nitrogen (BUN), estimated glomerular filtration rate (eGFR) and albuminuria. Additionally, miR-127-3p was elevated in T2DM and DKD patients. It could distinguish healthy individuals from T2DM or T2DM from DKD. In HG-induced HMC, miR-127-3p inhibitor elevated the cell viability and the levels of SOD while suppressing the levels of MDA. These effects were abolished by ACO2 silencing. Furthermore, downregulated miR-127-3p reduced the levels of TNF-\u03b1, IL-1\u03b2 and IL-6. sh-ACO2 alleviated the inhibitory effects of miR-127-3p.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Upregulated miR-127-3p was involved in the progression of T2DM and DKD. In HG-induced HMC, down-regulated miR-127-3p improved cell viability and suppressed oxidative stress and inflammatory responses by negatively regulating ACO2.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-025-00618-x","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T23:52:29Z","timestamp":1764978749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The diagnostic value and mechanism of miR-127-3p in type 2 diabetes and complications of diabetic nephropathy"],"prefix":"10.1186","volume":"163","author":[{"given":"Lili","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingbo","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoxia","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meini","family":"Cen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"key":"618_CR1","doi-asserted-by":"publisher","unstructured":"Elfaki I, Mir R, Almowallad S, Almassabi RF, Albalawi W, Albalawi AD, et al. Whole exome sequencing in 26 Saudi patients expands the mutational and clinical spectrum of diabetic nephropathy. Medicina. 2025;61(6). https:\/\/doi.org\/10.3390\/medicina61061017.","DOI":"10.3390\/medicina61061017"},{"issue":"9","key":"618_CR2","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.2337\/dci23-0030","volume":"46","author":"SC Naaman","year":"2023","unstructured":"Naaman SC, Bakris GL. Diabetic nephropathy: update on pillars of therapy slowing progression. Diabetes Care. 2023;46(9):1574\u201386. https:\/\/doi.org\/10.2337\/dci23-0030.","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"618_CR3","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1681\/asn.2004110970","volume":"16","author":"FP Schena","year":"2005","unstructured":"Schena FP, Gesualdo L. Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrology: JASN. 2005;16(Suppl 1):S30\u20133. https:\/\/doi.org\/10.1681\/asn.2004110970.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"6","key":"618_CR4","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.1002\/edm2.453","volume":"6","author":"YE Dean","year":"2023","unstructured":"Dean YE, Elawady SS, Shi W, Salem AA, Chotwatanapong A, Ashraf H, et al. Progression of diabetic nephropathy and vitamin D serum levels: A pooled analysis of 7722 patients. Endocrinol Diabetes Metabolism. 2023;6(6):e453. https:\/\/doi.org\/10.1002\/edm2.453.","journal-title":"Endocrinol Diabetes Metabolism"},{"key":"618_CR5","unstructured":"Rout P, Jialal I, Doerr C. Diabetic Nephropathy (Nursing). StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Ishwarlal Jialal declares no relevant financial relationships with ineligible companies. Disclosure: Chaddie Doerr declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright \u00a9. 2025, StatPearls Publishing LLC.; 2025."},{"issue":"51","key":"618_CR6","doi-asserted-by":"publisher","first-page":"e40952","DOI":"10.1097\/md.0000000000040952","volume":"103","author":"J Ma","year":"2024","unstructured":"Ma J, Ma DW. Advancements in the application of precision nursing model on Hemodialysis for diabetic nephropathy: A review. Medicine. 2024;103(51):e40952. https:\/\/doi.org\/10.1097\/md.0000000000040952.","journal-title":"Medicine"},{"key":"618_CR7","doi-asserted-by":"publisher","first-page":"8719060","DOI":"10.1155\/2019\/8719060","volume":"2019","author":"J Tang","year":"2019","unstructured":"Tang J, Yao D, Yan H, Chen X, Wang L, Zhan H. The role of MicroRNAs in the pathogenesis of diabetic nephropathy. Int J Endocrinol. 2019;2019:8719060. https:\/\/doi.org\/10.1155\/2019\/8719060.","journal-title":"Int J Endocrinol"},{"issue":"5","key":"618_CR8","doi-asserted-by":"publisher","first-page":"e70052","DOI":"10.1111\/nep.70052","volume":"30","author":"C Hao","year":"2025","unstructured":"Hao C, Li C, Wang J, Yu S. Diagnostic value and mechanism of action of serum miR-1281 involved in T2DM and complications of DKD. Nephrology. 2025;30(5):e70052. https:\/\/doi.org\/10.1111\/nep.70052.","journal-title":"Nephrology"},{"issue":"1","key":"618_CR9","doi-asserted-by":"publisher","first-page":"2484632","DOI":"10.1080\/0886022x.2025.2484632","volume":"47","author":"J Zhang","year":"2025","unstructured":"Zhang J, Cai Y, Qin Y, Liu J, Ding J, Xu M, et al. miR-1225-3p regulates fibrosis in mesangial cells via SMURF2-mediated ubiquitination of ChREBP in diabetic kidney disease. Ren Fail. 2025;47(1):2484632. https:\/\/doi.org\/10.1080\/0886022x.2025.2484632.","journal-title":"Ren Fail"},{"key":"618_CR10","doi-asserted-by":"publisher","unstructured":"Strycharz J, Wr\u00f3blewski A, Zieleniak A, \u015awiderska E, Matyjas T, Ruci\u0144ska M, et al. Visceral adipose tissue of prediabetic and diabetic females shares a set of similarly upregulated MicroRNAs functionally annotated to Inflammation, oxidative stress and insulin signaling. Antioxidants. 2021;10(1). https:\/\/doi.org\/10.3390\/antiox10010101.","DOI":"10.3390\/antiox10010101"},{"issue":"6","key":"618_CR11","doi-asserted-by":"publisher","first-page":"e70054","DOI":"10.1111\/nep.70054","volume":"30","author":"X Ji","year":"2025","unstructured":"Ji X, Nie S, Li X, Liu H, Du X, Fan L. MSC-Derived Exosomal MiR-127-3p alleviates acute kidney Ischemia-Reperfusion injury via suppressing ATG5\/ATG7-Mediated autophagy. Nephrology. 2025;30(6):e70054. https:\/\/doi.org\/10.1111\/nep.70054.","journal-title":"Nephrology"},{"key":"618_CR12","doi-asserted-by":"publisher","first-page":"747616","DOI":"10.3389\/fimmu.2021.747616","volume":"12","author":"L Wu","year":"2021","unstructured":"Wu L, Han X, Jiang X, Ding H, Qi C, Yin Z, et al. Downregulation of renal Hsa-miR-127-3p contributes to the overactivation of type I interferon signaling pathway in the kidney of lupus nephritis. Front Immunol. 2021;12:747616. https:\/\/doi.org\/10.3389\/fimmu.2021.747616.","journal-title":"Front Immunol"},{"issue":"1","key":"618_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13098-021-00709-5","volume":"13","author":"D Zhu","year":"2021","unstructured":"Zhu D, Wu X, Xue Q. Long non-coding RNA CASC2 restrains high glucose-induced proliferation, inflammation and fibrosis in human glomerular mesangial cells through mediating miR-135a-5p\/TIMP3 axis and JNK signaling. Diabetol Metab Syndr. 2021;13(1):89. https:\/\/doi.org\/10.1186\/s13098-021-00709-5.","journal-title":"Diabetol Metab Syndr"},{"key":"618_CR14","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.2147\/rmhp.S354549","volume":"17","author":"DF Duan","year":"2024","unstructured":"Duan DF, Wen Y, Yan Y, Li L, Xiao X, Li X, et al. Chinese healthcare workers\u2019 Knowledge, Attitudes, and practices in diabetic kidney management: A Multi-Centered Cross-Sectional study. Risk Manage Healthc Policy. 2024;17:1211\u201325. https:\/\/doi.org\/10.2147\/rmhp.S354549.","journal-title":"Risk Manage Healthc Policy"},{"issue":"4","key":"618_CR15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4062\/biomolther.2020.204","volume":"29","author":"V Natesan","year":"2021","unstructured":"Natesan V, Kim SJ. Diabetic Nephropathy - a review of risk Factors, Progression, Mechanism, and dietary management. Biomolecules Ther. 2021;29(4):365\u201372. https:\/\/doi.org\/10.4062\/biomolther.2020.204.","journal-title":"Biomolecules Ther"},{"issue":"2","key":"618_CR16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2337\/cd23-0063","volume":"42","author":"NA ElSayed","year":"2024","unstructured":"ElSayed NA, Bannuru RR, Bakris G, Bardsley J, de Boer IH, Gabbay RA, et al. Diabetic kidney disease prevention care model development. Clin Diabetes: Publication Am Diabetes Association. 2024;42(2):274\u201394. https:\/\/doi.org\/10.2337\/cd23-0063.","journal-title":"Clin Diabetes: Publication Am Diabetes Association"},{"issue":"2","key":"618_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4239\/wjd.v15.i2.186","volume":"15","author":"XY Chai","year":"2024","unstructured":"Chai XY, Bao XY, Dai Y, Dai XX, Zhang Y, Yang YL. Experience of humanistic nursing in Hemodialysis nursing for patients with diabetic kidney disease. World J Diabetes. 2024;15(2):186\u201395. https:\/\/doi.org\/10.4239\/wjd.v15.i2.186.","journal-title":"World J Diabetes"},{"issue":"1","key":"618_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000500353","volume":"50","author":"G Comai","year":"2019","unstructured":"Comai G, Malvi D, Angeletti A, Vasuri F, Valente S, Ambrosi F, et al. Histological evidence of diabetic kidney disease precede clinical diagnosis. Am J Nephrol. 2019;50(1):29\u201336. https:\/\/doi.org\/10.1159\/000500353.","journal-title":"Am J Nephrol"},{"key":"618_CR19","doi-asserted-by":"publisher","unstructured":"Tejera-Mu\u00f1oz A, Marchant V, Tejedor-Santamar\u00eda L, Opazo-R\u00edos L, Lavoz C, Gimeno-Longas MJ, et al. The role of miR-802 in diabetic kidney disease: diagnostic and therapeutic insights. Int J Mol Sci. 2025;26(12). https:\/\/doi.org\/10.3390\/ijms26125474.","DOI":"10.3390\/ijms26125474"},{"key":"618_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/fgene.2020.00237","volume":"11","author":"S Tang","year":"2020","unstructured":"Tang S, Cheng J, Yao Y, Lou C, Wang L, Huang X, et al. Combination of four serum Exosomal MiRNAs as novel diagnostic biomarkers for Early-Stage gastric cancer. Front Genet. 2020;11:237. https:\/\/doi.org\/10.3389\/fgene.2020.00237.","journal-title":"Front Genet"},{"key":"618_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.yjmcc.2024.05.010","volume":"193","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wu Y, Wang C, Hu W, Zou S, Ren H, et al. MiR-127-3p enhances macrophagic proliferation via disturbing fatty acid profiles and oxidative phosphorylation in atherosclerosis. J Mol Cell Cardiol. 2024;193:36\u201352. https:\/\/doi.org\/10.1016\/j.yjmcc.2024.05.010.","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"618_CR22","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1089\/dna.2021.0726","volume":"41","author":"H Lu","year":"2022","unstructured":"Lu H, Yang Y, Ou S, Qi Y, Li G, He H, et al. miRNA-382-5p carried by extracellular vesicles in osteoarthritis reduces cell viability and Proliferation, and promotes cell apoptosis by targeting PTEN. DNA Cell Biol. 2022;41(12):1012\u201325. https:\/\/doi.org\/10.1089\/dna.2021.0726.","journal-title":"DNA Cell Biol"},{"issue":"9","key":"618_CR23","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s10529-020-02906-0","volume":"42","author":"J Li","year":"2020","unstructured":"Li J, Wang G, Jiang J, Zhang L, Zhou P, Ren H. MicroRNA-127-3p regulates myoblast proliferation by targeting Sept7. Biotechnol Lett. 2020;42(9):1633\u201344. https:\/\/doi.org\/10.1007\/s10529-020-02906-0.","journal-title":"Biotechnol Lett"},{"issue":"3","key":"618_CR24","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.4049\/jimmunol.1402088","volume":"194","author":"H Ying","year":"2015","unstructured":"Ying H, Kang Y, Zhang H, Zhao D, Xia J, Lu Z et al. MiR-127 modulates macrophage polarization and promotes lung inflammation and injury by activating the JNK pathway. J Immunol (Baltimore, Md: 1950). 2015;194(3):1239-51. https:\/\/doi.org\/10.4049\/jimmunol.1402088.","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"issue":"3\u20134","key":"618_CR25","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10534-006-9047-6","volume":"20","author":"TW Tong","year":"2007","unstructured":"Tong TW, Rouault TA. Metabolic regulation of citrate and iron by aconitases: role of iron-sulfur cluster biogenesis. Biometals: Int J Role Metal Ions Biology Biochem Med. 2007;20(3\u20134):549\u201364. https:\/\/doi.org\/10.1007\/s10534-006-9047-6.","journal-title":"Biometals: Int J Role Metal Ions Biology Biochem Med"},{"issue":"23","key":"618_CR26","doi-asserted-by":"publisher","first-page":"e5126","DOI":"10.21769\/BioProtoc.5126","volume":"14","author":"WH Tong","year":"2024","unstructured":"Tong WH, Rouault TA. In-Gel activity assay of mammalian mitochondrial and cytosolic Aconitases, surrogate markers of Compartment-Specific oxidative stress and iron status. Bio-protocol. 2024;14(23):e5126. https:\/\/doi.org\/10.21769\/BioProtoc.5126.","journal-title":"Bio-protocol"},{"issue":"4","key":"618_CR27","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.21873\/anticanres.16299","volume":"43","author":"D Jaworski","year":"2023","unstructured":"Jaworski D, Kowalewski A, Dur\u015blewicz J, Antosik P, Smoli\u0144ska M, Grzanka D, et al. The prognostic role of ACO2 in renal cell carcinoma. Anticancer Res. 2023;43(4):1503\u201311. https:\/\/doi.org\/10.21873\/anticanres.16299.","journal-title":"Anticancer Res"},{"issue":"2","key":"618_CR28","doi-asserted-by":"publisher","first-page":"e0281439","DOI":"10.1371\/journal.pone.0281439","volume":"18","author":"J Wei","year":"2023","unstructured":"Wei J, Zhang J, Wei J, Hu M, Chen X, Qin X, et al. Identification of AGXT2, SHMT1, and ACO2 as important biomarkers of acute kidney injury by WGCNA. PLoS ONE. 2023;18(2):e0281439. https:\/\/doi.org\/10.1371\/journal.pone.0281439.","journal-title":"PLoS ONE"},{"key":"618_CR29","doi-asserted-by":"publisher","first-page":"992827","DOI":"10.3389\/fendo.2022.992827","volume":"13","author":"T Liu","year":"2022","unstructured":"Liu T, Wang Y, Zhao M, Jiang J, Li T, Zhang M. Differential expression of aerobic oxidative metabolism-related proteins in diabetic urinary exosomes. Front Endocrinol. 2022;13:992827. https:\/\/doi.org\/10.3389\/fendo.2022.992827.","journal-title":"Front Endocrinol"},{"issue":"1","key":"618_CR30","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1038\/s41467-023-39393-6","volume":"14","author":"E Kim","year":"2023","unstructured":"Kim E, Annibal A, Lee Y, Park HH, Ham S, Jeong DE, et al. Mitochondrial aconitase suppresses immunity by modulating oxaloacetate and the mitochondrial unfolded protein response. Nat Commun. 2023;14(1):3716. https:\/\/doi.org\/10.1038\/s41467-023-39393-6.","journal-title":"Nat Commun"},{"key":"618_CR31","doi-asserted-by":"publisher","first-page":"103399","DOI":"10.1016\/j.redox.2024.103399","volume":"77","author":"J Jiao","year":"2024","unstructured":"Jiao J, Gao G, Zhu J, Wang C, Liu L, Yang H. Binding of \u03b1-synuclein to ACO2 promotes progressive mitochondrial dysfunction in parkinson\u2019s disease models. Redox Biol. 2024;77:103399. https:\/\/doi.org\/10.1016\/j.redox.2024.103399.","journal-title":"Redox Biol"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00618-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00618-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00618-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:05:40Z","timestamp":1768341940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-025-00618-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["618"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00618-x","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from the ethics committee of Shenzhen Second People\u2019s Hospital. The procedures used in this study adhere to the tenets of the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}